Patents Assigned to Bayer
  • Publication number: 20060003418
    Abstract: The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.
    Type: Application
    Filed: August 26, 2005
    Publication date: January 5, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Clark Pan, James Whelan, Kevin Clairmont
  • Publication number: 20060004206
    Abstract: Process for the preparation of 2-aminomethylpyridine derivative of general formula (I) or a salt thereof, formula (I) in which:-n represents 0, 1, 2 or 3,-X is halogen atom,-each Y may be the same or different and may be a halogen atom, a halogenoalkyl, an alkoxycarbonyl or an alkylsulphonyl.
    Type: Application
    Filed: November 18, 2003
    Publication date: January 5, 2006
    Applicant: BAYER CROPSCIENCE S.A.
    Inventor: Manuel Vangelisti
  • Publication number: 20060003417
    Abstract: The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.
    Type: Application
    Filed: August 26, 2005
    Publication date: January 5, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Clark Pan, James Whelan, Kevin Clairmont
  • Publication number: 20060003934
    Abstract: The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.
    Type: Application
    Filed: August 26, 2005
    Publication date: January 5, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Clark Pan, James Whelan, Kevin Clairmont
  • Publication number: 20060004011
    Abstract: This invention relates to a compound of Formula I (I) and its use in treating hyper-proliferative disorders and diseases associated with angiogenesis.
    Type: Application
    Filed: November 10, 2003
    Publication date: January 5, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Gaetan Ladouceur, Brian Bear, Cheng Bi, David Brittelli, Michael Burke, Gang Chen, James Cook, Jacques Dumas, Robert Sibley, Michael Turner
  • Patent number: 6982299
    Abstract: A low gloss thermoplastic molding composition comprising a grafted acrylate rubber (ASA) and a process for its preparation are disclosed. The composition contains an effective amount of a gloss-reducing agent that is the reaction product of (i) compound having two or more maleic anhydride groups per molecule and (ii) compound having two or more terminal primary amine groups per molecule. The incorporation of the gloss reducing agent in the inventive composition may be by blending the reaction product or, in the alternative, blending the reactants (i) and (ii) in the molten ASA under process conditions designed to bring about the in situ formation of the inventive gloss reducing agent.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: January 3, 2006
    Assignees: Lanxess Corporation, Bayer Aktiengesellschaft
    Inventors: Moh-Ching Oliver Chang, Allen R. Padwa, Chuan-Ju Chen, Daniel Dufour
  • Patent number: 6982315
    Abstract: The invention relates to a process for the preparation of carboxamides, in particular peptides, from an acid component in the form of a compound containing at least one carboxyl group and an amine component in the form of a compound containing at least one primary or secondary amino group, and its use.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: January 3, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Joachim Rudolph, Günther Jung, Bernd Thern
  • Publication number: 20050288366
    Abstract: This invention relates to methods for treating cardiovascular disorder selected from heart failure, thromboembolic disorders, venous diseases, and fibrotic disorders other than fibrosis of the liver, comprising administering an effective amount of a compound of formula (I) in which the several variables are as defined in the specification and claims.
    Type: Application
    Filed: August 22, 2005
    Publication date: December 29, 2005
    Applicant: Bayer Aktiengesellschaft
    Inventors: Michael Harter, Michael Hahn, Claudia Hirth-Dietrich, Andreas Knorr, Elke Stahl, Johannes-Peter Stasch, Frank Wunder
  • Publication number: 20050288248
    Abstract: The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.
    Type: Application
    Filed: August 26, 2005
    Publication date: December 29, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Clark Pan, James Whelan, Kevin Clairmont
  • Publication number: 20050283274
    Abstract: The robot alignment system is used for establishing a predetermined alignment position between a movable robot member and an article that is processed by the robot. The system includes a laser transmitter that emits a focused laser beam and a target against which the focused laser beam is directed. The laser transmitter is preferably supported by the robot and the target is supported by the article that is processed by the robot. A signaling device cooperates with the target to produce a detectable signal when the focused laser beam is received at a predetermined location on the target. The detectable signal signifies establishment of a predetermined alignment position between the robot and the article that is processed by the robot.
    Type: Application
    Filed: June 18, 2004
    Publication date: December 22, 2005
    Applicant: BAYER CORPORATION
    Inventor: David Kleinschmitt
  • Publication number: 20050282707
    Abstract: A description is given of pyridinylisoxazoles of the formula (I) or salts thereof. In this formula (I) Q is one of the radicals Q1, Q2 or Q3; R1, R2 and R3 are various radicals, and n is 0 to 2.
    Type: Application
    Filed: June 17, 2005
    Publication date: December 22, 2005
    Applicant: Bayer CropScience GmbH
    Inventors: Andreas Almsick, Lothar Willms, Thomas Auler, Martin Hills, Heinz Kehne, Dieter Feucht, Dorothee Hoischen
  • Publication number: 20050282710
    Abstract: A description is given of derivatives of benzoylcyclohexanediones of the formula (I) and of their use as herbicides. In this formula (I) R1 and R2 are different radicals and Het is a saturated heterocyclic group comprising oxygen atoms and carbon atoms.
    Type: Application
    Filed: June 17, 2005
    Publication date: December 22, 2005
    Applicant: Bayer CropScience GmbH
    Inventors: Andreas Van Almsick, Lothar Willms, Thomas Auler, Christopher Rosinger, Heinz Kehne, Martin Hills, Dieter Feucht
  • Publication number: 20050282709
    Abstract: A description is given of benzoylpyrazoles of the formula (I) and of their use as herbicides. In this formula (I) R1, R2, R6, R7 and R8 are different radicals and Het is a saturated heterocyclic group including oxygen atoms and carbon atoms.
    Type: Application
    Filed: June 17, 2005
    Publication date: December 22, 2005
    Applicant: Bayer CropScience GmbH
    Inventors: Andreas van Almsick, Lothar Willms, Thomas Auler, Christopher Rosinger, Heinz Kehne, Martin Hills, Dieter Feucht
  • Patent number: 6977279
    Abstract: The present invention relates to novel solventless reactive systems curable at room temperature, based on blocked polyisocyanates, primary amines, compounds with oxirane groups, and 2,3-dimethyl-3,4,5,6-tetrahydropyrimidine, and to processes for the preparation of these solventless reactive systems curable at room temperature.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: December 20, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Jörg Tillack, Wolfgang Puetz, Lutz Schmalstieg
  • Patent number: 6977290
    Abstract: The present invention relates to a method for preparing oligomeric aliphatic diols, polycarbonatediols based thereon and NCO-terminated prepolymers obtainable therefrom. The inventive compounds may find use in the preparation of polyurethanes.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: December 20, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hartmut Nefzger, Erika Bauer, Manfred Schmidt, Hans-Dieter Ruprecht, James-Michael Barnes
  • Patent number: 6977289
    Abstract: The invention relates to new blocked polyurethane prepolymers, a process for their production and reactive systems produced therefrom that harden at room temperature, and their use.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: December 20, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Kamelia Detig-Karlou, Joachim Simon, Malte Homann, Thomas Stingl, Jörg Tillack
  • Publication number: 20050277640
    Abstract: Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R2, G, G?, and G? represent substituent groups and R2a represents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and methods of using these compounds in treatment of hyperproliferative diseases such as cancer are also disclosed and claimed.
    Type: Application
    Filed: March 10, 2005
    Publication date: December 15, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Julie Dixon, Dhanapalan Nagarathnam, Lei Zhang, Chunguang Wang, Lin Yi, Yuanwei Chen, Jianqing Chen, Brian Bear, Michael Brands, Alexander Hillisch, Donald Bierer, Ming Wang, Wenlang Fu, Martin Hentemann, Ann-Marie Bullion, Manoj Patel
  • Patent number: 6974880
    Abstract: The present invention relates to a process for the manufacture of diisocyanates by phosgenation of the corresponding diamines in which the vaporous diamines, optionally rarefied with an inert gas or with the vapors of an inert solvent, and phosgene are heated separately to temperatures of about 200° C. to about 600° C. and mixed and reacted in a tube reactor characterized in that a number n?2 of nozzles directed parallel to the axis of the tube reactor are arranged in the tube reactor, the diamine-containing stream being fed into the tube reactor through the n nozzles and the phosgene stream being fed into the tube reactor through the remaining free space.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: December 13, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Biskup, Peter Keldenich, Peter Fuhrmann, Christian Six
  • Patent number: 6974827
    Abstract: The present invention relates to novel compounds of the formula (I) in which W, X, Y, Z, G, A, B, Q1, Q2 and D are each as defined in the description, to a plurality of processes for their preparation and to their use as pesticides and herbicides.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: December 13, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Reiner Fischer, Alan Graff, Axel Trautwein, Astrid Ullmann, Udo Schneider, Ralf Wischnat, Mark Wilhelm Drewes, Christoph Erdelen, Dieter Feucht
  • Patent number: 6974874
    Abstract: The invention relates to a process for reducing the monomeric aziridine content in a polyaziridine forming reaction mixture by adding to the polyaziridine forming reaction mixture an excess of a carbodiimide scavenger wherein the excess is based on the equivalent ratio of scavenger to monomeric aziridine, and to a product obtained by this process and to a coating composition containing the product obtained by the process.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: December 13, 2005
    Assignee: Bayer MaterialScience LLC
    Inventors: Lanny D. Venham, Myron W. Shaffer, Karsten Danielmeier, Karen M. Henderson